Bhutan

Bhutan

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.62 (2.53 - 2.73) 2019 Modelled IHME
2.67 (2.57 - 2.77) 2018 Modelled IHME
2.74 (2.63 - 2.85) 2017 Modelled IHME
2.84 (2.74 - 2.95) 2016 Modelled IHME
2.97 (2.85 - 3.09) 2015 Modelled IHME
3.07 (2.95 - 3.19) 2014 Modelled IHME
3.17 (3.05 - 3.29) 2013 Modelled IHME
3.26 (3.14 - 3.39) 2012 Modelled IHME
3.36 (3.23 - 3.49) 2011 Modelled IHME
3.46 (3.32 - 3.60) 2010 Modelled IHME
3.57 (3.43 - 3.71) 2009 Modelled IHME
3.69 (3.54 - 3.83) 2008 Modelled IHME
3.81 (3.66 - 3.96) 2007 Modelled IHME
3.94 (3.77 - 4.09) 2006 Modelled IHME
4.07 (3.89 - 4.23) 2005 Modelled IHME
4.2 (4.02 - 4.36) 2004 Modelled IHME
4.34 (4.14 - 4.49) 2003 Modelled IHME
4.48 (4.27 - 4.64) 2002 Modelled IHME
4.62 (4.39 - 4.79) 2001 Modelled IHME
4.76 (4.50 - 4.95) 2000 Modelled IHME
4.92 (4.62 - 5.11) 1999 Modelled IHME
5.1 (4.73 - 5.31) 1998 Modelled IHME
5.27 (4.85 - 5.51) 1997 Modelled IHME
5.42 (4.95 - 5.68) 1996 Modelled IHME
5.53 (4.97 - 5.81) 1995 Modelled IHME
5.6 (5.06 - 5.88) 1994 Modelled IHME
5.67 (5.10 - 5.96) 1993 Modelled IHME
5.72 (5.13 - 6.01) 1992 Modelled IHME
5.76 (5.16 - 6.06) 1991 Modelled IHME
5.77 (5.17 - 6.08) 1990 Modelled IHME
4.29 (3.31 - 5.55) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.16 (0.13 - 0.17) 2019 Modelled IHME
0.16 (0.14 - 0.17) 2018 Modelled IHME
0.16 (0.14 - 0.18) 2017 Modelled IHME
0.17 (0.14 - 0.18) 2016 Modelled IHME
0.17 (0.14 - 0.19) 2015 Modelled IHME
0.18 (0.15 - 0.20) 2014 Modelled IHME
0.2 (0.16 - 0.22) 2013 Modelled IHME
0.21 (0.18 - 0.24) 2012 Modelled IHME
0.22 (0.19 - 0.25) 2011 Modelled IHME
0.23 (0.20 - 0.26) 2010 Modelled IHME
0.23 (0.20 - 0.26) 2009 Modelled IHME
0.23 (0.19 - 0.25) 2008 Modelled IHME
0.22 (0.19 - 0.25) 2007 Modelled IHME
0.22 (0.19 - 0.25) 2006 Modelled IHME
0.22 (0.19 - 0.25) 2005 Modelled IHME
0.23 (0.20 - 0.26) 2004 Modelled IHME
0.28 (0.24 - 0.31) 2003 Modelled IHME
0.35 (0.31 - 0.39) 2002 Modelled IHME
0.45 (0.39 - 0.50) 2001 Modelled IHME
0.57 (0.49 - 0.63) 2000 Modelled IHME
1.01 (0.86 - 1.13) 1999 Modelled IHME
1.9 (1.60 - 2.13) 1998 Modelled IHME
2.93 (2.44 - 3.29) 1997 Modelled IHME
3.79 (3.12 - 4.27) 1996 Modelled IHME
4.21 (3.39 - 4.76) 1995 Modelled IHME
4.28 (3.49 - 4.81) 1994 Modelled IHME
4.35 (3.54 - 4.86) 1993 Modelled IHME
4.39 (3.57 - 4.91) 1992 Modelled IHME
4.42 (3.58 - 4.96) 1991 Modelled IHME
4.43 (3.56 - 5.01) 1990 Modelled IHME
0.81 (0.55 - 1.22) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
35,335 (31,668 - 37,228) 1990 Modelled IHME
33,996 (30,444 - 35,753) 1991 Modelled IHME
33,070 (29,652 - 34,774) 1992 Modelled IHME
32,847 (29,570 - 34,538) 1993 Modelled IHME
32,872 (29,716 - 34,530) 1994 Modelled IHME
33,044 (29,744 - 34,772) 1995 Modelled IHME
33,050 (30,149 - 34,637) 1996 Modelled IHME
32,791 (30,153 - 34,268) 1997 Modelled IHME
32,247 (29,947 - 33,564) 1998 Modelled IHME
31,546 (29,603 - 32,746) 1999 Modelled IHME
30,872 (29,180 - 32,072) 2000 Modelled IHME
30,234 (28,772 - 31,347) 2001 Modelled IHME
29,553 (28,194 - 30,619) 2002 Modelled IHME
28,822 (27,519 - 29,869) 2003 Modelled IHME
28,042 (26,802 - 29,111) 2004 Modelled IHME
27,319 (26,099 - 28,422) 2005 Modelled IHME
26,731 (25,598 - 27,757) 2006 Modelled IHME
26,261 (25,185 - 27,230) 2007 Modelled IHME
25,909 (24,864 - 26,882) 2008 Modelled IHME
25,605 (24,550 - 26,589) 2009 Modelled IHME
25,320 (24,255 - 26,326) 2010 Modelled IHME
25,011 (24,030 - 25,980) 2011 Modelled IHME
24,573 (23,642 - 25,516) 2012 Modelled IHME
24,016 (23,107 - 24,954) 2013 Modelled IHME
23,378 (22,456 - 24,317) 2014 Modelled IHME
22,646 (21,737 - 23,588) 2015 Modelled IHME
21,699 (20,909 - 22,516) 2016 Modelled IHME
20,811 (19,992 - 21,670) 2017 Modelled IHME
20,196 (19,499 - 20,946) 2018 Modelled IHME
19,770 (19,088 - 20,594) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
6.97 (4.36 - 12.60) 2019 Modelled IHME
6.82 (4.24 - 12.50) 2018 Modelled IHME
6.69 (4.17 - 12.10) 2017 Modelled IHME
6.56 (4.09 - 11.90) 2016 Modelled IHME
6.48 (4.05 - 11.60) 2015 Modelled IHME
6.44 (4.06 - 11.60) 2014 Modelled IHME
6.42 (4.08 - 11.50) 2013 Modelled IHME
6.43 (4.13 - 11.30) 2012 Modelled IHME
6.5 (4.17 - 11.50) 2011 Modelled IHME
6.61 (4.26 - 11.60) 2010 Modelled IHME
7.04 (4.55 - 12.30) 2009 Modelled IHME
7.82 (5.06 - 13.60) 2008 Modelled IHME
8.65 (5.73 - 15) 2007 Modelled IHME
9.18 (6.11 - 16) 2006 Modelled IHME
9.47 (6.32 - 16.60) 2005 Modelled IHME
9.45 (6.31 - 16.40) 2004 Modelled IHME
9.39 (6.31 - 16.40) 2003 Modelled IHME
9.25 (6.26 - 15.60) 2002 Modelled IHME
9.25 (6.19 - 15.40) 2001 Modelled IHME
9.22 (6.26 - 15.20) 2000 Modelled IHME
8.96 (6.10 - 14.60) 1999 Modelled IHME
9.06 (6.15 - 14.30) 1998 Modelled IHME
8.98 (6.05 - 14.10) 1997 Modelled IHME
8.91 (6 - 13.90) 1996 Modelled IHME
8.94 (5.99 - 14.10) 1995 Modelled IHME
8.85 (5.91 - 14.10) 1994 Modelled IHME
8.76 (5.85 - 13.80) 1993 Modelled IHME
8.62 (5.61 - 13.60) 1992 Modelled IHME
8.38 (5.47 - 12.90) 1991 Modelled IHME
8 (5.01 - 12.60) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
53 (33 - 95) 2019 Modelled IHME
52 (32 - 94) 2018 Modelled IHME
51 (32 - 92) 2017 Modelled IHME
50 (31 - 91) 2016 Modelled IHME
49 (31 - 89) 2015 Modelled IHME
49 (31 - 88) 2014 Modelled IHME
49 (31 - 87) 2013 Modelled IHME
48 (31 - 85) 2012 Modelled IHME
48 (31 - 86) 2011 Modelled IHME
48 (31 - 85) 2010 Modelled IHME
50 (33 - 88) 2009 Modelled IHME
55 (36 - 95) 2008 Modelled IHME
60 (39 - 103) 2007 Modelled IHME
62 (41 - 108) 2006 Modelled IHME
64 (42 - 111) 2005 Modelled IHME
63 (42 - 110) 2004 Modelled IHME
62 (42 - 109) 2003 Modelled IHME
61 (41 - 103) 2002 Modelled IHME
61 (41 - 101) 2001 Modelled IHME
60 (41 - 99) 2000 Modelled IHME
57 (39 - 93) 1999 Modelled IHME
57 (39 - 91) 1998 Modelled IHME
56 (38 - 88) 1997 Modelled IHME
54 (37 - 85) 1996 Modelled IHME
53 (36 - 85) 1995 Modelled IHME
52 (35 - 83) 1994 Modelled IHME
51 (34 - 80) 1993 Modelled IHME
50 (32 - 78) 1992 Modelled IHME
49 (32 - 76) 1991 Modelled IHME
49 (31 - 77) 1990 Modelled IHME
122 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
25 (18 - 33) 2019 Modelled IHME
25 (18 - 33) 2018 Modelled IHME
25 (18 - 33) 2017 Modelled IHME
25 (18 - 33) 2016 Modelled IHME
25 (18 - 33) 2015 Modelled IHME
25 (19 - 33) 2014 Modelled IHME
25 (19 - 33) 2013 Modelled IHME
25 (19 - 33) 2012 Modelled IHME
25 (19 - 33) 2011 Modelled IHME
25 (19 - 33) 2010 Modelled IHME
25 (19 - 34) 2009 Modelled IHME
26 (20 - 35) 2008 Modelled IHME
27 (20 - 35) 2007 Modelled IHME
28 (21 - 36) 2006 Modelled IHME
28 (21 - 37) 2005 Modelled IHME
28 (21 - 36) 2004 Modelled IHME
28 (21 - 37) 2003 Modelled IHME
28 (21 - 37) 2002 Modelled IHME
28 (21 - 36) 2001 Modelled IHME
28 (21 - 37) 2000 Modelled IHME
29 (22 - 37) 1999 Modelled IHME
29 (22 - 38) 1998 Modelled IHME
29 (22 - 38) 1997 Modelled IHME
29 (22 - 38) 1996 Modelled IHME
30 (22 - 39) 1995 Modelled IHME
30 (23 - 39) 1994 Modelled IHME
30 (23 - 39) 1993 Modelled IHME
30 (23 - 39) 1992 Modelled IHME
31 (23 - 39) 1991 Modelled IHME
31 (23 - 40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
96 2018 Survey/reported WHO/UNICEF
95 2017 Survey/reported WHO/UNICEF
82 2016 Survey/reported WHO/UNICEF
78 2015 Survey/reported WHO/UNICEF
78 2014 Survey/reported WHO/UNICEF
64 2013 Survey/reported WHO/UNICEF
60 2012 Survey/reported WHO/UNICEF
29 2011 Survey/reported WHO/UNICEF
86 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
97 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
95 2011 Survey/reported WHO/UNICEF
91 2010 Survey/reported WHO/UNICEF
93 2009 Survey/reported WHO/UNICEF
96 2008 Survey/reported WHO/UNICEF
95 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
95 2005 Survey/reported WHO/UNICEF
89 2004 Survey/reported WHO/UNICEF
95 2003 Survey/reported WHO/UNICEF
83 2002 Survey/reported WHO/UNICEF
89 2001 Survey/reported WHO/UNICEF
98 2000 Survey/reported WHO/UNICEF
90 1999 Survey/reported WHO/UNICEF
81 1998 Survey/reported WHO/UNICEF
84 1997 Survey/reported WHO/UNICEF
16 1996 Survey/reported WHO/UNICEF
97 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2011
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.85 (0.69 - 1.04) 2019 Modelled IHME
0.85 (0.69 - 1.04) 2018 Modelled IHME
0.85 (0.69 - 1.04) 2017 Modelled IHME
0.84 (0.69 - 1.03) 2016 Modelled IHME
0.84 (0.68 - 1.03) 2015 Modelled IHME
0.84 (0.68 - 1.03) 2014 Modelled IHME
0.84 (0.68 - 1.03) 2013 Modelled IHME
0.84 (0.68 - 1.03) 2012 Modelled IHME
0.84 (0.68 - 1.03) 2011 Modelled IHME
0.85 (0.68 - 1.04) 2010 Modelled IHME
0.85 (0.68 - 1.04) 2009 Modelled IHME
0.85 (0.69 - 1.05) 2008 Modelled IHME
0.86 (0.69 - 1.05) 2007 Modelled IHME
0.86 (0.69 - 1.06) 2006 Modelled IHME
0.86 (0.69 - 1.07) 2005 Modelled IHME
0.85 (0.69 - 1.04) 2004 Modelled IHME
0.82 (0.67 - 0.99) 2003 Modelled IHME
0.78 (0.64 - 0.94) 2002 Modelled IHME
0.75 (0.62 - 0.90) 2001 Modelled IHME
0.74 (0.61 - 0.89) 2000 Modelled IHME
0.74 (0.61 - 0.89) 1999 Modelled IHME
0.75 (0.61 - 0.89) 1998 Modelled IHME
0.75 (0.62 - 0.91) 1997 Modelled IHME
0.76 (0.62 - 0.91) 1996 Modelled IHME
0.76 (0.63 - 0.92) 1995 Modelled IHME
0.76 (0.63 - 0.92) 1994 Modelled IHME
0.77 (0.63 - 0.92) 1993 Modelled IHME
0.77 (0.63 - 0.93) 1992 Modelled IHME
0.77 (0.63 - 0.93) 1991 Modelled IHME
0.77 (0.63 - 0.93) 1990 Modelled IHME
Showing out of
Show more

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
4,706 (3,865 - 5,677) 1990 Modelled IHME
4,536 (3,723 - 5,477) 1991 Modelled IHME
4,436 (3,640 - 5,348) 1992 Modelled IHME
4,440 (3,649 - 5,347) 1993 Modelled IHME
4,486 (3,679 - 5,397) 1994 Modelled IHME
4,558 (3,739 - 5,487) 1995 Modelled IHME
4,623 (3,786 - 5,533) 1996 Modelled IHME
4,678 (3,836 - 5,637) 1997 Modelled IHME
4,715 (3,873 - 5,653) 1998 Modelled IHME
4,745 (3,895 - 5,708) 1999 Modelled IHME
4,786 (3,936 - 5,748) 2000 Modelled IHME
4,916 (4,046 - 5,891) 2001 Modelled IHME
5,159 (4,220 - 6,235) 2002 Modelled IHME
5,434 (4,424 - 6,599) 2003 Modelled IHME
5,661 (4,589 - 6,950) 2004 Modelled IHME
5,779 (4,651 - 7,153) 2005 Modelled IHME
5,831 (4,711 - 7,183) 2006 Modelled IHME
5,897 (4,762 - 7,255) 2007 Modelled IHME
5,983 (4,824 - 7,338) 2008 Modelled IHME
6,081 (4,895 - 7,444) 2009 Modelled IHME
6,189 (4,988 - 7,600) 2010 Modelled IHME
6,288 (5,085 - 7,694) 2011 Modelled IHME
6,346 (5,145 - 7,751) 2012 Modelled IHME
6,373 (5,173 - 7,803) 2013 Modelled IHME
6,388 (5,195 - 7,842) 2014 Modelled IHME
6,399 (5,213 - 7,866) 2015 Modelled IHME
6,425 (5,232 - 7,895) 2016 Modelled IHME
6,446 (5,225 - 7,908) 2017 Modelled IHME
6,445 (5,215 - 7,846) 2018 Modelled IHME
6,443 (5,200 - 7,858) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
6.78 (4.27 - 11.70) 2019 Modelled IHME
6.74 (4.30 - 11.60) 2018 Modelled IHME
6.67 (4.27 - 11.60) 2017 Modelled IHME
6.54 (4.20 - 11.40) 2016 Modelled IHME
6.45 (4.08 - 11.30) 2015 Modelled IHME
6.38 (4.03 - 11.20) 2014 Modelled IHME
6.31 (4.01 - 11) 2013 Modelled IHME
6.24 (3.97 - 10.80) 2012 Modelled IHME
6.21 (3.98 - 10.60) 2011 Modelled IHME
6.2 (4.01 - 10.60) 2010 Modelled IHME
6.06 (3.94 - 10.10) 2009 Modelled IHME
5.76 (3.75 - 9.60) 2008 Modelled IHME
5.45 (3.58 - 8.98) 2007 Modelled IHME
5.17 (3.43 - 8.39) 2006 Modelled IHME
5.08 (3.36 - 8.21) 2005 Modelled IHME
5.03 (3.32 - 8.26) 2004 Modelled IHME
4.99 (3.31 - 8.08) 2003 Modelled IHME
4.91 (3.25 - 7.94) 2002 Modelled IHME
4.91 (3.23 - 7.84) 2001 Modelled IHME
4.88 (3.19 - 7.87) 2000 Modelled IHME
4.72 (3.09 - 7.67) 1999 Modelled IHME
4.73 (3.16 - 7.50) 1998 Modelled IHME
4.65 (3.08 - 7.48) 1997 Modelled IHME
4.58 (3.01 - 7.15) 1996 Modelled IHME
4.57 (3.06 - 7.08) 1995 Modelled IHME
4.52 (2.99 - 6.98) 1994 Modelled IHME
4.47 (2.94 - 6.90) 1993 Modelled IHME
4.39 (2.86 - 6.71) 1992 Modelled IHME
4.26 (2.71 - 6.65) 1991 Modelled IHME
4.06 (2.44 - 6.21) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
51 (32 - 88) 2019 Modelled IHME
51 (33 - 88) 2018 Modelled IHME
51 (32 - 88) 2017 Modelled IHME
50 (32 - 87) 2016 Modelled IHME
49 (31 - 86) 2015 Modelled IHME
49 (31 - 85) 2014 Modelled IHME
48 (30 - 83) 2013 Modelled IHME
47 (30 - 81) 2012 Modelled IHME
46 (30 - 79) 2011 Modelled IHME
45 (29 - 77) 2010 Modelled IHME
43 (28 - 72) 2009 Modelled IHME
40 (26 - 67) 2008 Modelled IHME
38 (25 - 62) 2007 Modelled IHME
35 (23 - 57) 2006 Modelled IHME
34 (23 - 55) 2005 Modelled IHME
34 (22 - 55) 2004 Modelled IHME
33 (22 - 54) 2003 Modelled IHME
32 (21 - 52) 2002 Modelled IHME
32 (21 - 51) 2001 Modelled IHME
32 (21 - 51) 2000 Modelled IHME
30 (20 - 49) 1999 Modelled IHME
30 (20 - 47) 1998 Modelled IHME
29 (19 - 47) 1997 Modelled IHME
28 (18 - 44) 1996 Modelled IHME
27 (18 - 42) 1995 Modelled IHME
27 (18 - 41) 1994 Modelled IHME
26 (17 - 40) 1993 Modelled IHME
25 (17 - 39) 1992 Modelled IHME
25 (16 - 39) 1991 Modelled IHME
25 (15 - 38) 1990 Modelled IHME
34 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
32 (23 - 41) 2019 Modelled IHME
32 (23 - 41) 2018 Modelled IHME
32 (23 - 42) 2017 Modelled IHME
32 (23 - 41) 2016 Modelled IHME
32 (23 - 41) 2015 Modelled IHME
32 (23 - 41) 2014 Modelled IHME
32 (23 - 41) 2013 Modelled IHME
31 (23 - 40) 2012 Modelled IHME
31 (23 - 40) 2011 Modelled IHME
31 (23 - 40) 2010 Modelled IHME
31 (22 - 40) 2009 Modelled IHME
30 (22 - 39) 2008 Modelled IHME
30 (22 - 39) 2007 Modelled IHME
30 (21 - 39) 2006 Modelled IHME
29 (21 - 38) 2005 Modelled IHME
29 (21 - 37) 2004 Modelled IHME
29 (20 - 37) 2003 Modelled IHME
28 (20 - 37) 2002 Modelled IHME
28 (20 - 36) 2001 Modelled IHME
28 (20 - 36) 2000 Modelled IHME
28 (20 - 36) 1999 Modelled IHME
27 (19 - 35) 1998 Modelled IHME
27 (19 - 35) 1997 Modelled IHME
27 (19 - 35) 1996 Modelled IHME
27 (19 - 35) 1995 Modelled IHME
26 (19 - 35) 1994 Modelled IHME
26 (18 - 35) 1993 Modelled IHME
26 (18 - 35) 1992 Modelled IHME
26 (18 - 35) 1991 Modelled IHME
26 (18 - 35) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2011
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
53
2019
(33 - 95)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
51
2019
(32 - 88)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
86 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines